Feature Articles
Lawrence Berkeley National Laboratory
.
Updates every hour. Last Updated: 18-May-2026 05:16 ET (18-May-2026 09:16 GMT/UTC)
11-Oct-2021
Controlling thin films with atomic “spray painting”
DOE/Pacific Northwest National Laboratory
Creating films with atomic precision allows researchers moving to the Energy Sciences Center to identify small, but important changes in the materials.
11-Oct-2021
EIC User Profile: Jennifer Rittenhouse West
DOE/Brookhaven National Laboratory
This story, profiling theoretical physicist Jennifer Rittenhouse West, is a pilot project conceived by the Software Working Group of the EIC User Group to become part of a series of profiles of future users of the Electron-Ion Collider (EIC). The EIC is a next-generation nuclear physics research facility being built at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory in partnership with DOE’s Thomas Jefferson National Accelerator Facility and collaborators around the world.
8-Oct-2021
Hydrogen can play key role in US decarbonization
DOE/Lawrence Berkeley National Laboratory
A Q&A with Berkeley Lab scientists on how hydrogen can help achieve net-zero emissions. Adam Weber is Berkeley Lab's Hydrogen and Fuel Cell Technologies Program Manager and leads Berkeley Lab’s Energy Conversion Group (ECG), and Ahmet Kusoglu is a staff scientist in the ECG, a multidisciplinary team of electrochemists, chemical engineers, mechanical engineers, theorists, and material scientists with active collaborations across industry, academia, and national laboratories.
7-Oct-2021
Argonne hosts summer school for nuclear energy scientists
DOE/Argonne National Laboratory
Argonne hosted the 13th annual Modeling, Experimentation and Validation Summer School July 19-30. National labs and industry helped fill a critical educational gap for the engineers and scientists who will shape the future of nuclear energy.
6-Oct-2021
A colorful, sustainable solution for 3D printing
DOE/Pacific Northwest National Laboratory
PNNL has developed seaweed-based inks and materials for 2-D and 3-D printing that can be used for a multitude of applications in the art, medical, STEM, and other fields.
6-Oct-2021
Sandia creates global archive of historical renewable energy documents
DOE/Sandia National Laboratories
Sandia National Laboratories’ solar researchers and librarians have spent the past few years collecting, digitizing and cataloging a host of reports, memos, blueprints, photos and more on concentrating solar power, a kind of renewable energy produced by using large mirrors to reflect and concentrate sunlight onto a receiver on a tower to generate electricity. These historical research documents are now in a publicly accessible digital archive for other concentrating solar power researchers, historians, corporations and citizens to view.
6-Oct-2021
Cell ‘fingerprinting’ could yield long-awaited alzheimer’s disease diagnostic
DOE/Lawrence Berkeley National Laboratory
Some devastating diseases, like Alzheimer's and autoimmune conditions, are hard to diagnose correctly because doctors don’t yet know what genes or molecules to look for. But this new technique inspired by the Star Trek tricorder can spot disease without the clues, using infrared light and machine learning.
- Journal
- Scientific Reports
6-Oct-2021
Brown takes new role with Climate Change Science Institute at ORNL
DOE/Oak Ridge National Laboratory
Marilyn Brown of the Georgia Institute of Technology recently began a joint faculty appointment, or JFA, with the Climate Change Science Institute at the Department of Energy’s Oak Ridge National Laboratory. As an internationally recognized leader in climate solutions and energy policy, Brown will collaborate with ORNL to apply insights from global climate science to inform regional strategies that reduce carbon emissions and equitably address impacts on communities.
5-Oct-2021
Osteoporosis drug may be a promising treatment for therapy-resistant breast cancer
DOE/Argonne National Laboratory
Researchers from Argonne and the University of Chicago have found that lasofoxifene, a drug used to treat osteoporosis, may be a safer and more effective treatment for breast cancer than the current gold standard. Clinical trials have begun.